|
1
|
Martinez-Barbera JP and Buslei R:
Adamantinomatous craniopharyngioma: Pathology, molecular genetics
and mouse models. J Pediatr Endocrinol Metab. 28:7–17. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kasai H, Hirano A, Llena JF and Kawamoto
K: A histopathological study of craniopharyngioma with special
reference to its stroma and surrounding tissue. Brain Tumor Pathol.
14:41–45. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barkhoudarian G and Laws ER:
Craniopharyngioma: History. Pituitary. 16:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Laws ER Jr: Transsphenoidal microsurgery
in the management of craniopharyngioma. J Neurosurg. 52:661–666.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Laws ER Jr: Transsphenoidal removal of
craniopharyngioma. Pediatr Neurosurg. 21 (Suppl 1):S57–S63. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yaşargil MG, Curcic M, Kis M, Siegenthaler
G, Teddy PJ and Roth P: Total removal of craniopharyngiomas.
Approaches and long-term results in 144 patients. J Neurosurg.
73:3–11. 1990. View Article : Google Scholar
|
|
7
|
Alvarez M: Craniopharyngiomas. J Neurosci
Nurs. 38:362–368. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karavitaki N, Cudlip S, Adams CB and Wass
JA: Craniopharyngiomas. Endocr Rev. 27:371–397. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gump JM, Donson AM, Birks DK, Amani VM,
Rao KK, Griesinger AM, Kleinschmidt-DeMasters BK, Johnston JM,
Anderson RC, Rosenfeld A, et al: Identification of targets for
rational pharmacological therapy in childhood craniopharyngioma.
Acta Neuropathol Commun. 3(30)2015.PubMed/NCBI
|
|
10
|
Xia Z, Liu W, Li S, Jia G, Zhang Y, Li C,
Ma Z, Tian J and Gong J: Expression of matrix metalloproteinase-9,
type IV collagen and vascular endothelial growth factor in
adamantinous craniopharyngioma. Neurochem Res. 36:2346–2351. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baker JC, Beddington RS and Harland RM:
Wnt signaling in Xenopus embryos inhibits bmp4 expression and
activates neural development. Genes Dev. 13:3149–3159. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li T, Gao X, Han L, Yu J and Li H:
Identification of hub genes with prognostic values in gastric
cancer by bioinformatics analysis. World J Surg Oncol. 16:1142018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi
ST, Siu HC, Deng S, Chu KM, Law S, et al: Whole-genome sequencing
and comprehensive molecular profiling identify new driver mutations
in gastric cancer. Nat Genet. 46:573–582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang P and Liu XS: Big data mining yields
novel insights on cancer. Nat Genet. 47:103–104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang F, Qian X, Lu Z, Lai Y, Li Z, He C
and He Z: Identification of differentially expressed genes,
biological pathways and prognostic signature in bladder cancer. BMC
Urology. 10.21203/rs.3.rs-362542/v1.
|
|
16
|
Werb Z and Gordon S: Elastase secretion by
stimulated macrophages. Characterization and regulation. J Exp Med.
42:361–377. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Banda MJ and Werb Z: Mouse macrophage
elastase. Purifcation and characterization as a metalloproteinase.
Biochem J. 193:589–605. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
White RR, Norby D, Janoff A and Dearing R:
Partial purifcation and characterization of mouse peritoneal
exudative macrophage elastase. Biochim Biophys Acta. 612:233–244.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hautamaki RD, Kobayashi DK, Senior RM and
Shapiro SD: Requirement for macrophage elastase for cigarette
smoke-induced emphysema in mice. Science. 277:2002–2004. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shipley JM, Wesselschmidt RL, Kobayashi
DK, Ley TJ and Shapiro SD: Metalloelastase is required for
macrophage-mediated proteolysis and matrix invasion in mice. Proc
Natl Acad Sci USA. 93:3942–3946. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marchant DJ, Bellac CL, Moraes TJ,
Wadsworth SJ, Dufour A, Butler GS, Bilawchuk LM, Hendry RG,
Robertson AG, Cheung CT, et al: A new transcriptional role for
matrix metalloproteinase-12 in antiviral immunity. Nat Med.
20:493–502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kerkelä E, Ala-Aho R, Jeskanen L, Rechardt
O, Grénman R, Shapiro SD, Kähäri VM and Saarialho-Kere U:
Expression of human macrophage metalloelastase (MMP-12) by tumor
cells in skin cancer. J Invest Dermatol. 114:1113–1119. 2000.
View Article : Google Scholar
|
|
23
|
Zhao X, Xu M, Cai Z, Yuan W, Cui W and Li
MD: Identifcation of LIFR, PIK3R1, and MMP12 as novel prognostic
signatures in gallbladder cancer using network-based module
analysis. Front Oncol. 9:3252019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roman J: On the ‘TRAIL’ of a killer: MMP12
in lung cancer. Am J Respir Crit Care Med. 196:262–264. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klupp F, Neumann L, Kahlert C, Diers J,
Halama N, Franz C, Schmidt T, Koch M, Weitz J, Schneider M and
Ulrich A: Serum MMP7, MMP10 and MMP12 level as negative prognostic
markers in colon cancer patients. BMC Cancer. 16:4942016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ng KT, Qi X, Kong KL, Cheung BY, Lo CM,
Poon RT, Fan ST and Man K: Overexpression of matrix
metalloproteinase-12 (MMP-12) correlates with poor prognosis of
hepatocellular carcinoma. Eur J Cancer. 47:2299–2305. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ella E, Harel Y, Abraham M, Wald H, Benny
O, Karsch-Bluman A, Vincent D, Laurent D, Amir G, Izhar U, et al:
Matrix metalloproteinase 12 promotes tumor propagation in the lung.
J Thorac Cardiovasc Surg. 155:2164–2175. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang W, Arii S, Gorrin-Rivas MJ, Mori A,
Onodera H and Imamura M: Human macrophage metalloelastase gene
expression in colorectal carcinoma and its clinicopathologic
signifcance. Cancer. 91:1277–1283. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kerkelä E, Ala-aho R, Klemi P, Grénman S,
Shapiro SD, Kähäri VM and Saarialho-Kere U: Metalloelastase
(MMP-12) expression by tumour cells in squamous cell carcinoma of
the vulva correlates with invasiveness, while that by macrophages
predicts better outcome. J Pathol. 198:258–269. 2002. View Article : Google Scholar
|
|
30
|
Chen S, Xie J, Zhao K, Ren L, Deng Y, Xie
X, Chen S, Xu H, Long X and Liu E: LPS aggravates lung inflammation
induced by RSV by promoting the ERK-MMP-12 signaling pathway in
mice. Respir Res. 21:1932020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li J, Wang JJ, Peng Q, Chen C, Humphrey
MB, Heinecke J and Zhang SX: Macrophage metalloelastase (MMP-12)
deficiency mitigates retinal inflammation and pathological
angiogenesis in ischemic retinopathy. PLoS One. 7:e526992012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Apps JR, Carreno G, Gonzalez-Meljem JM,
Haston S, Guiho R, Cooper JE, Manshaei S, Jani N, Hölsken A,
Pettorini B, et al: Tumour compartment transcriptomics demonstrates
the activation of inflammatory and odontogenic programmes in human
adamantinomatous craniopharyngioma and identifies the MAPK/ERK
pathway as a novel therapeutic target. Acta Neuropathol.
135:757–777. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gupta S, Bi WL, Giantini Larsen A,
Al-Abdulmohsen S, Abedalthagafi M and Dunn IF: Craniopharyngioma: A
roadmap for scientific translation. Neurosurg Focus. 44:E122018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gene Expression Omnibus: Series GSE94349,
. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE94349February
1–2017
|
|
35
|
Gene Expression Omnibus: Series GSE68015,
. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68015April
18–2015
|
|
36
|
Wang F, Xue Q, Xu D, Jiang Y, Tang C and
Liu X: Identifying the hub gene in gastric cancer by bioinformatics
analysis and in vitro experiments. Cell Cycle. 19:1326–1337. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yin X, Liu Z, Zhu P, Wang Y, Ren Q, Chen H
and Xu J: CXCL12/CXCR4 promotes proliferation, migration, and
invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal
pathway. J Cell Biochem. 120:9724–9736. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Adamson TE, Wiestler OD, Kleihues P and
Yasargil MG: Correlation of clinical and pathological features in
surgically treated craniopharyngiomas. J Neurosurg. 73:12–17. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nelson WG, Battifora H, Santana H and Sun
TT: Specific keratins as molecular markers for neoplasms with a
stratified epithelial origin. Cancer Res. 44:1600–1603.
1984.PubMed/NCBI
|
|
40
|
Quentmeier H, Osborn M, Reinhardt J,
Zaborski M and Drexler HG: Immunocytochemical analysis of cell
lines derived from solid tumors. J Histochem Cytochem.
49:1369–1378. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang N: Vimentin and tumor diagnosis.
Zhonghua Bing Li Xue Za Zhi. 19:122–124. 1990.(In Chinese).
PubMed/NCBI
|
|
42
|
Zimmerli D, Hausmann G, Cantù C and Basler
K: Pharmacological interventions in the Wnt pathway: Inhibition of
Wnt secretion versus disrupting the protein-protein interfaces of
nuclear factors. Br J Pharmacol. 174:4600–4610. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chelluboina B, Nalamolu KR, Klopfenstein
JD, Pinson DM, Wang DZ, Vemuganti R and Veeravalli KK: MMP-12, a
promising therapeutic target for neurological diseases. Mol
Neurobiol. 55:1405–1409. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bunin GR, Surawicz TS, Witman PA,
Preston-Martin S, Davis F and Bruner JM: The descriptive
epidemiology of craniopharyngioma. Neurosurg Focus. 3:e11997.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Erfurth EM, Holmer H and Fjalldal SB:
Mortality and morbidity in adult craniopharyngioma. Pituitary.
16:46–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006–2010. Neuro Oncol. 15
(Suppl 2):ii1–ii56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Brennan A, Leech JT, Kad NM and Mason JM:
Selective antagonism of cJun for cancer therapy. J Exp Clin Cancer
Res. 39:1842020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gurbuz I and Chiquet-Ehrismann R:
CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): A focus on
its role in cancer. Int J Biochem Cell Biol. 62:142–146. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Panda S, Banerjee N and Chatterjee S:
Solute carrier proteins and c-Myc: A strong connection in cancer
progression. Drug Discovery Today. 25:891–900. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yang M, Zhang X, Liu Q, Niu T, Jiang L, Li
H, Kuang J, Qi C, Zhang Q, He X, et al: Knocking out matrix
metalloproteinase 12 causes the accumulation of M2 macrophages in
intestinal tumor microenvironment of mice. Cancer Immunol
Immunother. 69:1409–1421. 2020. View Article : Google Scholar : PubMed/NCBI
|
